Phosphorus Metabolism Disorders - 25 Studies Found Completed : A Phase III Study of PA21 in Peritoneal Dialysis Patients With Hyperphosphatemia : Peritoneal Dialysis Hyperphosphatemia : 2013-05-07 : Drug: PA21 Completed : A Phase III Study of PA21 With Calcium Carbonate in Hemodialysis Patients With Hyperphosphatemia : Hemodialysis Hyperphosphatemia : 2013-05-07 : Drug: PA21 Completed : A Phase III Study of PA21 in Hemodialysis Patients With Hyperphosphatemia : Hemodialysis Hyperphosphatemia : 2013-05-07 : Drug: PA21 Drug: Sevelamer hydrochloride Completed : A Long-term Study of PA21 in Hemodialysis Patients With Hyperphosphatemia : Hemodialysis Patients With Hyperphosphatemia : 2013-04-12 : Drug: PA21 Completed : Long Term Evaluation of Sevelamer HCl vs. Calcium-based Phosphate Binder in the Treatment of Hyperphosphatemia in Hemodialysis Patients : Hemodialysis Hyperphosphatemia Cardiovascular Events : 2012-12-19 : Drug: Sevelamer HCl Non-metal Recruiting : A Comparison of Lanthanum Carbonate and Calcium Carbonate in Children : Hyperphosphatemia : 2012-09-26 : Drug: Lanthanum carbonate Subj Active, not recruiting : Outcome Study of Lanthanum Carbonate Compared With Calcium Carbonate in Hemodialysis Patients : Landmark Study : Hemodialysis Hyperphosphatemia : 2012-04-13 : Drug: Lanthanum Carbonate Drug: Calcium Ca Completed : Open Study of BAY77-1931 (Lanthanum Carbonate) in Continuous Ambulatory Peritoneal Dialysis Patients : Hyperphosphatemia : 2012-01-18 : Drug: Lanthanum Carbonate (BAY77-1931) Completed : Phase III Double-blind Comparative Study of BAY77-1931 (Lanthanum Carbonate) With Calcium Carbonate : Hyperphosphatemia : 2012-01-18 : Drug: Lanthanum carbonate (BAY77-1931) Dru Completed : Non-interventional Study to Evaluate the Ease of Reaching Individual Goals in Serum Phosphorus (Steering) : Hyperphosphataemia ESRD : 2011-08-26 <<< Previous | Next >>>